• Twitter
AMIVAS IRELAND LTD
  • ABOUT AMIVAS
    • GLOBAL GOALS
  • OUR PRODUCT
  • PARTNERING
  • NEWS
  • CAREERS
  • LIBRARY
  • CONTACT
  • Search
  • Menu Menu

Amivas Ireland Ltd NEWS RELEASES

Press Releases

AMIVAS Ireland Ltd. Receives Authorisation from the Medicines & Healthcare Products Regulatory Agency (MHRA) to Market Artesunate Amivas (artesunate) in U.K. for Initial Treatment of Severe Malaria

Read more
13 June 2022
https://amivas.eu/wp-content/uploads/2021/12/amivas-logo-300x126.png 0 0 Admin https://amivas.eu/wp-content/uploads/2021/12/amivas-logo-300x126.png Admin2022-06-13 23:00:562022-06-13 10:43:48AMIVAS Ireland Ltd. Receives Authorisation from the Medicines & Healthcare Products Regulatory Agency (MHRA) to Market Artesunate Amivas (artesunate) in U.K. for Initial Treatment of Severe Malaria
Press Releases

Artesunate for Injection gains FDA Approval

Read more
27 May 2020
https://amivas.eu/wp-content/uploads/2021/12/amivas-logo-300x126.png 0 0 Admin https://amivas.eu/wp-content/uploads/2021/12/amivas-logo-300x126.png Admin2020-05-27 00:00:002020-05-27 12:41:37Artesunate for Injection gains FDA Approval

Media contact info

Method Health Communications

P: 484-667-6330
E: methodhealthcomms@gmail.com

News Media Resources
© 2021 Amivas Ireland Ltd. All rights reserved | Site by WordPress Hosting
  • Twitter
Scroll to top